dacomitinib
- 中文别名:达克替尼
- 中文释义:EGFR抑制剂;达克米替尼;PF299804;(2E)-N-[4-[(3-氯-4-氟苯基)氨基]-7-甲氧基-6-喹唑啉基]-4-(1-哌啶基)-2-丁烯酰胺
- 英文别名:(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide;
Dacomitinib [USAN];
(2e)-N-{4-[(3-Chloro-4-Fluorophenyl)amino]-7-Methoxyquinazolin-6-Yl}-4-(Piperidin-1-Yl)but-2-Enamide;
(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide;
Dacomitinib (USAN/INN);
Dacomitinib
- CAS No.:1110813-31-4
- 分子式:
C24H25ClFN5O2
- 分子量:469.9462
- 精确分子量:469.16800
- PSA:82.87000
- InChI:InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+
- 分子结构式:
热门化工词典词汇
- 5-(1-ethyl-5-methylpyrazol-4-yl)-1,2-oxazole-3-carboxylic acid5-(1-乙基-5-甲基-1H-吡唑-4-基)-异恶唑-3-羧酸
- 2-Propenoicacid,2-hydroxyethylester,polymerwith.alpha.-hydro-.omega.-hydroxypoly(oxy-1,4-butanediyl)and1,1-methylenebis[42-丙烯酸-2-羟乙基酯与&alpha
- dimethyl bicyclo[2.2.1]heptane-2,3-dicarboxylatedimethyl bicyclo[2.2.1]heptane-2,3-dicarboxylate
- 3,4-dibromonaphthalene-1,2-dione3,4-二溴-1,2-萘二酮
- 3-Pyridinemethanol,5,6-dichloro-5,6-二氯-3-嘧啶甲醇
- 5-methylsulfonylthiophene-2-carbaldehyde5-(甲基磺酰基)-2-噻吩甲醛
- 1,1'-(1,3-Propanediyl)bis[1,1-bis(2-methoxy-5-methylphenyl)phosphine]1,1'-(1,3-丙二基)双[1,1-双(2-甲氧基-5-甲基苯基)膦]
- 2,4,6(1H,3H,5H)-Pyrimidinetrione,5-methyl-5-METHYLPYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE
- 4-(6-Methoxy-pyriMidin-4-ylaMino)-piperidine-1-carboxylic acid tert-butyl ester4-(6-甲氧基-嘧啶-4-基氨基)-哌啶-1-羧酸叔丁基酯
- 1-bromo-6-methylcyclohexene1-溴-6-甲基环己烯